A detailed history of Prime Capital Investment Advisors, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 35,337 shares of PACB stock, worth $52,298. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,337
Holding current value
$52,298
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$1.55 - $2.65 $54,772 - $93,643
35,337 New
35,337 $64,000
Q2 2023

Aug 08, 2023

SELL
$9.97 - $14.05 $17,417 - $24,545
-1,747 Reduced 8.31%
19,286 $256,000
Q1 2023

May 05, 2023

BUY
$7.94 - $12.02 $167,002 - $252,816
21,033 New
21,033 $243,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $333M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.